HEALTH● LOWJun 23 · Jun 23, 2026, 11:34 AM
AbbVie, Enanta announce EU label expansion for hepatitis C therapy, Maviret
Seeking Alpha Tech
AbbVie and Enanta have announced an EU label expansion for their hepatitis C therapy, Maviret. This expansion broadens the approved usage of the drug in the European Union.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH41m agoPope Leo XIV sends message after surgery to Vatican conference , asks for prayersewtnnews.com · United StatesHEALTH41m agoMichelle Grattan | Labor reintroduces health insurance rebate | The Canberra Timescanberratimes.com.au · AustraliaHEALTH1h agoFDA advances peptide push to White HouseThe HillHEALTH1h agoThe average hospital stay is getting more expensive , new survey findsktvq.com · United States